• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Hepatitis-B reactivation and rituximab-containing chemotherapy: An increasingly complex clinical challenge

PA Thompson, CS Tam, K Thursky, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2010

DOI: 10.3109/10428194.2010.509456

University of Melbourne Researchers

Philip Thompson's Profile Picture
Philip Thompson Author

Constantine Tam's Profile Picture
Constantine Tam Author

Kas Thursky's Profile Picture
Kas Thursky Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

7Scopus
5Web of Science
8Dimensions

Keywords

32 Biomedical and Clinical Sciences
Hepatitis
Surface-Antigen
Hepatitis - C
Emerging Infectious Diseases
3 Good Health and Well Being
6.1 Pharmaceuticals
Chronic Liver Disease and Cirrhosis
Cytotoxic Chemotherapy
Carriers
Oncology
Life Sciences & Biomedicine
Liver Disease
Hbv Reactivation
Hematology
Digestive Diseases
Prophylactic Lamivudine
Science & Technology
Cancer-Patients
Risk
Virus Reactivation
Lymphoma
3201 Cardiovascular Medicine and Haematology
Hepatitis - B
Cancer
Infectious Diseases
Preemptive Lamivudine

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224